随着网络普及，大数据应用越来越广泛，大数据在带给人们便捷的同时其安全性能的安全防护问题也需要人们进行重点研究。文章主要分析了在大数据背景下计算机网络信息存在的安全隐患，并提出安全防护的技术建设，旨在为提高大数据背景下计算机网络信息的安全性。

The research provides an overview of all the M&As and divestitures in the medtech industry during the study period. The M&As focus on three primary areas: The clinical specialty areas where the M&As occur. The purpose behind these deals. The impact of the consolidated landscape on healthcare providers, payers, patients, and other market players.

The global healthcare information technology sector has witnessed strong growth in recent years. Digitization and new technological opportunities have played a major role in driving the growth of the sector. Also, the healthcare IT sector includes a broad range of products and solutions, which are widely contributing to the efficiency and effectiveness of the global healthcare infrastructure. Several industry trends that are fueling the demand for products and services across the healthcare IT industry include Artificial Intelligence (AI), telehealth services, individualized medical care, virtual reality, automation, and digitalization.

Access Layer: Also called the edge layer, the access switches are connected at the top of the rack and thus can also be defined as top-of-the rack switches. Aggregation Layer: Also called the distributor layer, the aggregation switches are connected to the access switches and provide benefits such as intrusion detection, network analysis, firewall, and others

All substances are toxic above a certain dose. Appropriate doses make the difference between poisons and medicines. According to Paracelsus, no drug is completely safe or effective under all circumstances, but it is moral that the manufacturers involved take appropriate steps to ensure optimal quality, safety, and efficacy. It is legally expected. Regulatory operations serve as a roadmap for the development of prescription drugs, biologics, and medical devices. Regulations focus on harmonization with international regulations, new drug applications, good manufacturing practices, quality system compliance, documentation requirements, clinical trial exceptions, expedited status, advisory board procedures, and other compliance issues.

Coronary artery disease (CAD), also known as coronary heart disease (CHD) or simply heart disease, develops when coronary arteries that supply blood, oxygen, and nutrients to the heart become damaged or diseased. Cholesterol-containing deposits (plaque formation) narrow the coronary arteries and decrease the blood flow to the heart, causing CAD. The decreased blood flow to the heart may cause angina and shortness of breath. Complete blockage of blood flow can lead to heart attack and permanent damage to the heart muscles. Furthermore, over time, CAD also weakens the heart muscles, leading to heart failure and abnormal heart rhythms called arrhythmias.

Over the last few years, the global pharmaceutical industry has undergone significant changes. In recent years, the cost of drugs has been increasing rapidly, a majority of which is contributed by funds allocated to research and development. According to a report published by Congressional Budget Office (CBO) in April 2021, titled, ‘Research and Development in the Pharmaceutical Industry,’ the U.S. pharmaceutical industry’s R&D expenditure in 2019 was nearly $83 billion, spanning a range of activities such as drug discovery, conducting clinical tests, and drug innovation, among others. Additionally, the report also states that the budget share allocated by pharmaceutical companies toward research and development has also increased. The following table shows a rough estimate of the annual R&D expenditure of pharmaceutical companies.

7月29日，快手举办“光合创作者大会”，大会包含创作者主题演讲、 答创作者问、变现专题、内容专题、工具专题5个环节，主要围绕平台 扶持创作者成长、创作者变现获利、提升创作者内容质量等问题展开 分享与讨论。